Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.
about
Meningococcal Antigen Typing System Development and Application to the Evaluation of Effectiveness of Meningococcal B Vaccine and Possible Use for Other PurposesRole of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseEmerging experience with meningococcal serogroup B protein vaccines.The effect of human factor H on immunogenicity of meningococcal native outer membrane vesicle vaccines with over-expressed factor H binding protein.Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa.A critical threshold of meningococcal factor H binding protein expression is required for increased breadth of protective antibodies elicited by native outer membrane vesicle vaccinesComplement-mediated bactericidal activity of anti-factor H binding protein monoclonal antibodies against the meningococcus relies upon blocking factor H binding.Meningococcal factor H binding proteins in epidemic strains from Africa: implications for vaccine development.Functional Analysis of the Human Antibody Response to Meningococcal Factor H Binding ProteinA broadly cross-reactive monoclonal antibody against an epitope on the n-terminus of meningococcal fHbp.The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens.Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor H.Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C VaccineImpaired Immunogenicity of Meningococcal Neisserial Surface Protein A in Human Complement Factor H Transgenic Mice.A meningococcal NOMV-FHbp vaccine for Africa elicits broader serum bactericidal antibody responses against serogroup B and non-B strains than a licensed serogroup B vaccineImportance of inhibition of binding of complement factor H for serum bactericidal antibody responses to meningococcal factor H-binding protein vaccinesDoes binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?Serum Bactericidal Antibody Responses of Adults Immunized with the MenB-4C Vaccine against Genetically Diverse Serogroup B Meningococci.Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.Bexsero: a multicomponent vaccine for prevention of meningococcal disease.Invasive meningococcal disease in the 21st century—an update for the clinician.Activation of the classical complement pathway by Bacillus anthracis is the primary mechanism for spore phagocytosis and involves the spore surface protein BclA.Immunization with alkyl hydroperoxide reductase subunit C reduces Fusobacterium nucleatum load in the intestinal tract.Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus.Breadth and Duration of Meningococcal Serum Bactericidal Activity in Health Care Workers and Microbiologists Immunized with the MenB-FHbp Vaccine.Discordant Effects of Licensed Meningococcal Serogroup B Vaccination on Invasive Disease and Nasal Colonization in a Humanized Mouse Model.A large portion of meningococcal antigen typing system-negative meningococcal strains from spain is killed by sera from adolescents and infants immunized with 4CMenB.Meningococcal omp85 in detergent-extracted outer membrane vesicle vaccines induces high levels of non-functional antibodies in mice.Meningococcal Antigen Typing System (MATS)-Based Neisseria meningitidis Serogroup B Coverage Prediction for the MenB-4C Vaccine in the United States.The role of anti-NHba antibody in bactericidal activity elicited by the meningococcal serogroup B vaccine, MenB-4C.Human protective response induced by meningococcus B vaccine is mediated by the synergy of multiple bactericidal epitopes.
P2860
Q26782318-F525E994-49F6-4D96-82B5-7665F9091C23Q26995760-FA319893-DEED-4A61-A5B3-3E05F75311A1Q30234958-286180F4-0D56-4115-B92A-0DCE4BC6F1F8Q34270429-8449979B-328D-4549-B5F7-013BCF5AB72CQ34785389-76F20E48-9200-4698-895A-8FB16F160C88Q35066132-37C2E230-762C-4E2A-BE85-42F914A19767Q35191862-D1100DB5-97FE-442C-B995-B4378360F9E1Q35198778-17CCCC59-4B5C-4567-AF9F-9936DC2DE964Q35777766-3F456644-8FA6-4447-85C2-3116AA194C85Q35857593-8D6F7866-8BD3-426E-834E-7D220A1834A6Q35989852-C7AD70F4-2FC1-4BF6-8F73-8BD5A2D029BEQ36211092-1AF5CD87-695A-47ED-B1C8-F3D18FD31491Q36316767-D15EC7B9-3D7A-4880-BAD3-F71414835166Q36513433-42F851AE-EA38-4C6F-98D9-9AAA7A4CFE48Q36521563-944DFAAB-9C24-4194-A7A1-5B3E35052A9CQ37037083-2DAB2A66-54AB-4983-B9D5-6A284873FEF7Q37124721-F358BAEF-391E-4765-AA50-F695E934D0FBQ37563627-91406CDC-66FF-4A73-82BE-E58AA9E31CC5Q37956384-1E5DA685-E857-4466-B2A8-6A859D629640Q37994540-89756C66-7BB5-4DF4-9801-CAB5505C27BCQ38338388-0BCB69ED-7F24-4AC6-8640-14255CF79AACQ39374965-94A8F2A5-A757-474F-95B1-300CCD0B857CQ40065611-818D4F15-DD12-4A70-B84A-DBE9FD120489Q40172533-B958C2C2-271F-46CB-B629-F04CC487E6DCQ40178578-1CFDB28B-1133-46A0-BD0E-31EC695E2520Q40268050-12B9A067-D9EC-45A2-A1F4-5B35E6FEBAD1Q41513468-412B6C00-AF81-4A3C-8B55-F059F9B21E86Q42269802-36D2A6FF-A2FE-467A-94FB-795ADF715DD9Q45824896-EB249A70-F7E4-4A1F-A603-57CCF0DDF8EAQ50922458-564B78F7-46EF-4DEB-AED2-4D53631AEDA9Q52682421-79726F35-C6A8-4936-A021-16836815CC24
P2860
Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigen.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cooperative serum bactericidal ...... erial heparin binding antigen.
@ast
Cooperative serum bactericidal ...... erial heparin binding antigen.
@en
Cooperative serum bactericidal ...... erial heparin binding antigen.
@nl
type
label
Cooperative serum bactericidal ...... erial heparin binding antigen.
@ast
Cooperative serum bactericidal ...... erial heparin binding antigen.
@en
Cooperative serum bactericidal ...... erial heparin binding antigen.
@nl
prefLabel
Cooperative serum bactericidal ...... erial heparin binding antigen.
@ast
Cooperative serum bactericidal ...... erial heparin binding antigen.
@en
Cooperative serum bactericidal ...... erial heparin binding antigen.
@nl
P2860
P1433
P1476
Cooperative serum bactericidal ...... serial heparin binding antigen
@en
P2093
Dan M Granoff
Tracy T Wong
P2860
P304
P356
10.1016/J.VACCINE.2010.12.075
P407
P50
P577
2011-01-15T00:00:00Z